by William B. White
When the COVID-19 pandemic was moved into the mainstream of global society, the research and scale-up of mRNA vaccines illustrated an impressive response based on an existing infrastructure throughout the life science community. Directing this response were major international health organizations marshaling the resources of a robust pharmaceutical industry already at work on a new generation of vaccines.
Vaccine storage has always been a matter of temperature uniformity and stability in commercial refrigeration systems. As new mRNA vaccines requiring non-traditional low temperatures for vaccines were placed onto the market at the height of the pandemic, the demand for ultra-low temperature (ULT) freezers set off a struggle between supply and demand that continues somewhat to this day. In the ultra-low freezer industry, it was chaos.
Read more on Labcompare.